» Articles » PMID: 36640457

Mechanisms of Cognitive Behavioral Therapy Vs. Supportive Psychotherapy in Body Dysmorphic Disorder: An Exploratory Mediation Analysis

Overview
Journal Behav Res Ther
Specialty Psychology
Date 2023 Jan 14
PMID 36640457
Authors
Affiliations
Soon will be listed here.
Abstract

Body dysmorphic disorder (BDD) is common, severe, and often chronic. Cognitive behavioral therapy (CBT) is the first-line psychosocial treatment for BDD, with well-established efficacy. However, some patients do not improve with CBT, and little is known about how CBT confers its effects. Neurocognitive processes have been implicated in the etiology and maintenance of BDD and are targeted by CBT-BDD treatment components. Yet, the malleability of these factors in BDD, and their potential role in mediating symptom improvement, are not well understood. Understanding how treatment works could help optimize treatment outcomes. In this secondary data analysis of a randomized clinical trial of CBT vs. supportive psychotherapy (SPT) in BDD (n = 120), we examined whether treatment-related changes in detail processing (Rey-Osterrieth Complex Figure test), maladaptive appearance beliefs (Appearance Schemas Inventory-Revised), and emotion recognition (Emotion Recognition Task) mediated treatment outcome. All constructs improved over time and were associated with symptom improvement. CBT was associated with greater improvements in maladaptive beliefs than SPT. None of the variables examined mediated symptom improvement. Findings suggest that with successful treatment, individuals with BDD demonstrate reduced neurocognitive deficits (detail processing, emotion recognition, maladaptive beliefs) and that CBT is more likely than SPT to improve maladaptive appearance beliefs. More work is needed to understand mechanisms of change and thus maximize treatment outcomes.

Citing Articles

Exploring the Intersection of Body Dysmorphic Disorder (BDD) and Dermatological Conditions: A Narrative Review.

Li V, Frasier K, Woolhiser E, Daly K, Christoforides S, Harpine C Dermatol Ther (Heidelb). 2024; 14(10):2693-2708.

PMID: 39266863 PMC: 11480305. DOI: 10.1007/s13555-024-01256-3.

References
1.
Gunstad J, Phillips K . Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003; 44(4):270-6. PMC: 1613797. DOI: 10.1016/S0010-440X(03)00088-9. View

2.
Weingarden H, Hoeppner S, Snorrason I, Greenberg J, Phillips K, Wilhelm S . Rates of remission, sustained remission, and recurrence in a randomized controlled trial of cognitive behavioral therapy versus supportive psychotherapy for body dysmorphic disorder. Depress Anxiety. 2021; . PMC: 8443701. DOI: 10.1002/da.23148. View

3.
Wilhelm S, Berman N, Keshaviah A, Schwartz R, Steketee G . Mechanisms of change in cognitive therapy for obsessive compulsive disorder: role of maladaptive beliefs and schemas. Behav Res Ther. 2014; 65:5-10. PMC: 4313532. DOI: 10.1016/j.brat.2014.12.006. View

4.
Feusner J, Moody T, Hembacher E, Townsend J, McKinley M, Moller H . Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. Arch Gen Psychiatry. 2010; 67(2):197-205. PMC: 2853756. DOI: 10.1001/archgenpsychiatry.2009.190. View

5.
Feusner J, Moller H, Altstein L, Sugar C, Bookheimer S, Yoon J . Inverted face processing in body dysmorphic disorder. J Psychiatr Res. 2010; 44(15):1088-94. PMC: 3285268. DOI: 10.1016/j.jpsychires.2010.03.015. View